Enterprise Ireland
Enterprise Ireland is a government agency based in Dublin, Ireland, established in 1998 to foster the growth and development of indigenous businesses. Its primary mission is to assist Irish enterprises in achieving a strong presence in global markets, thereby enhancing national and regional prosperity. The agency supports a wide range of companies, from high-potential start-ups to established businesses, by providing funding, resources, and guidance. Additionally, Enterprise Ireland collaborates with college-based researchers to facilitate the development and commercialization of innovative technologies through licensing and spin-out companies. By focusing on innovation and export sales, Enterprise Ireland plays a crucial role in driving economic growth and competitiveness within the Irish economy.
Top Stages
Past deals in Infants
NeuroBell
Seed Round in 2024
NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.
CergenX
Seed Round in 2023
CergenX is a company specializing in neonatal brain monitoring technology that leverages artificial intelligence to identify newborn infants at risk of brain injury. It develops advanced algorithms and systems designed to screen for brain abnormalities in babies by analyzing brain wave patterns. This technology enables healthcare professionals to detect abnormal activity and potential brain injuries early, facilitating timely intervention and care. CergenX's innovative approach aims to improve outcomes for vulnerable newborns through enhanced monitoring and detection capabilities.
NeuroBell
Grant in 2023
NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.
CergenX
Seed Round in 2022
CergenX is a company specializing in neonatal brain monitoring technology that leverages artificial intelligence to identify newborn infants at risk of brain injury. It develops advanced algorithms and systems designed to screen for brain abnormalities in babies by analyzing brain wave patterns. This technology enables healthcare professionals to detect abnormal activity and potential brain injuries early, facilitating timely intervention and care. CergenX's innovative approach aims to improve outcomes for vulnerable newborns through enhanced monitoring and detection capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.